Cargando…

Novel protocol for optimal utilization of HPSD approach for pulmonary vein isolation

BACKGROUND: The efficiency of pulmonary vein isolation (PVI) depends on the durability of RF lesions. Recent studies documented sustained continuity of ablation lines, improvements in durability, and expected clinical outcomes through altered settings in duration and power. However, the ablation str...

Descripción completa

Detalles Bibliográficos
Autores principales: Manukyan, Hayarpi, Szegedi, Nandor, Pavlović, Nikola, Blessberger, Herman, Fiedler, Lucas, Krieger, Konstantin, Manola, Šime, Nagy, Vivien K., Roithinger, Franz Xaver, Salló, Zoltán, Steinwender, Clemens, Gellér, László, Matschuck, Guido A., Kosiuk, Jedrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407163/
https://www.ncbi.nlm.nih.gov/pubmed/37560278
http://dx.doi.org/10.1002/joa3.12868
_version_ 1785085895137820672
author Manukyan, Hayarpi
Szegedi, Nandor
Pavlović, Nikola
Blessberger, Herman
Fiedler, Lucas
Krieger, Konstantin
Manola, Šime
Nagy, Vivien K.
Roithinger, Franz Xaver
Salló, Zoltán
Steinwender, Clemens
Gellér, László
Matschuck, Guido A.
Kosiuk, Jedrzej
author_facet Manukyan, Hayarpi
Szegedi, Nandor
Pavlović, Nikola
Blessberger, Herman
Fiedler, Lucas
Krieger, Konstantin
Manola, Šime
Nagy, Vivien K.
Roithinger, Franz Xaver
Salló, Zoltán
Steinwender, Clemens
Gellér, László
Matschuck, Guido A.
Kosiuk, Jedrzej
author_sort Manukyan, Hayarpi
collection PubMed
description BACKGROUND: The efficiency of pulmonary vein isolation (PVI) depends on the durability of RF lesions. Recent studies documented sustained continuity of ablation lines, improvements in durability, and expected clinical outcomes through altered settings in duration and power. However, the ablation strategy has not been adapted to this new approach and different biophysics of lesion formation. PURPOSE: The aim of this study was to demonstrate that by adjusting the ablation approach to the broader geometry of lesions by increasing the minimal spacing between adjacent RF, a further significant reduction of procedural time while maintaining sufficient long‐term outcomes is achievable. METHODS: The presented study was a prospective, observational multi‐center trial. The periprocedural data were compared with data from a consecutively collected historical cohort. RESULTS: In total, 196 patients were included (mean age 62 ± 11 years, male 64.3%). Procedural duration, RF time, and LA dwelling time were significantly shorter in the HPSD group compared with the standard group (73 ± 26 min vs. 98 ± 36 min, p < .001; 14 ± 7 min vs. 33 ± 12 min, p < .001; and 59 ± 21 min vs. 77 ± 32 min, p < .001, respectively). Mean AF‐free survival in the first year of follow‐up was 304 ± 14 days in the HPSD group versus 340 ± 10 days in the standard group (log‐rank p = .403). There were no statistically significant differences in the complication rates between the groups. CONCLUSION: Increasing the minimal distance between individual application points simplifies AF ablation and further reduces procedure time without negative effects on efficacy and safety. Larger studies are needed to optimally utilize this approach.
format Online
Article
Text
id pubmed-10407163
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-104071632023-08-09 Novel protocol for optimal utilization of HPSD approach for pulmonary vein isolation Manukyan, Hayarpi Szegedi, Nandor Pavlović, Nikola Blessberger, Herman Fiedler, Lucas Krieger, Konstantin Manola, Šime Nagy, Vivien K. Roithinger, Franz Xaver Salló, Zoltán Steinwender, Clemens Gellér, László Matschuck, Guido A. Kosiuk, Jedrzej J Arrhythm Original Articles BACKGROUND: The efficiency of pulmonary vein isolation (PVI) depends on the durability of RF lesions. Recent studies documented sustained continuity of ablation lines, improvements in durability, and expected clinical outcomes through altered settings in duration and power. However, the ablation strategy has not been adapted to this new approach and different biophysics of lesion formation. PURPOSE: The aim of this study was to demonstrate that by adjusting the ablation approach to the broader geometry of lesions by increasing the minimal spacing between adjacent RF, a further significant reduction of procedural time while maintaining sufficient long‐term outcomes is achievable. METHODS: The presented study was a prospective, observational multi‐center trial. The periprocedural data were compared with data from a consecutively collected historical cohort. RESULTS: In total, 196 patients were included (mean age 62 ± 11 years, male 64.3%). Procedural duration, RF time, and LA dwelling time were significantly shorter in the HPSD group compared with the standard group (73 ± 26 min vs. 98 ± 36 min, p < .001; 14 ± 7 min vs. 33 ± 12 min, p < .001; and 59 ± 21 min vs. 77 ± 32 min, p < .001, respectively). Mean AF‐free survival in the first year of follow‐up was 304 ± 14 days in the HPSD group versus 340 ± 10 days in the standard group (log‐rank p = .403). There were no statistically significant differences in the complication rates between the groups. CONCLUSION: Increasing the minimal distance between individual application points simplifies AF ablation and further reduces procedure time without negative effects on efficacy and safety. Larger studies are needed to optimally utilize this approach. John Wiley and Sons Inc. 2023-05-15 /pmc/articles/PMC10407163/ /pubmed/37560278 http://dx.doi.org/10.1002/joa3.12868 Text en © 2023 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Manukyan, Hayarpi
Szegedi, Nandor
Pavlović, Nikola
Blessberger, Herman
Fiedler, Lucas
Krieger, Konstantin
Manola, Šime
Nagy, Vivien K.
Roithinger, Franz Xaver
Salló, Zoltán
Steinwender, Clemens
Gellér, László
Matschuck, Guido A.
Kosiuk, Jedrzej
Novel protocol for optimal utilization of HPSD approach for pulmonary vein isolation
title Novel protocol for optimal utilization of HPSD approach for pulmonary vein isolation
title_full Novel protocol for optimal utilization of HPSD approach for pulmonary vein isolation
title_fullStr Novel protocol for optimal utilization of HPSD approach for pulmonary vein isolation
title_full_unstemmed Novel protocol for optimal utilization of HPSD approach for pulmonary vein isolation
title_short Novel protocol for optimal utilization of HPSD approach for pulmonary vein isolation
title_sort novel protocol for optimal utilization of hpsd approach for pulmonary vein isolation
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407163/
https://www.ncbi.nlm.nih.gov/pubmed/37560278
http://dx.doi.org/10.1002/joa3.12868
work_keys_str_mv AT manukyanhayarpi novelprotocolforoptimalutilizationofhpsdapproachforpulmonaryveinisolation
AT szegedinandor novelprotocolforoptimalutilizationofhpsdapproachforpulmonaryveinisolation
AT pavlovicnikola novelprotocolforoptimalutilizationofhpsdapproachforpulmonaryveinisolation
AT blessbergerherman novelprotocolforoptimalutilizationofhpsdapproachforpulmonaryveinisolation
AT fiedlerlucas novelprotocolforoptimalutilizationofhpsdapproachforpulmonaryveinisolation
AT kriegerkonstantin novelprotocolforoptimalutilizationofhpsdapproachforpulmonaryveinisolation
AT manolasime novelprotocolforoptimalutilizationofhpsdapproachforpulmonaryveinisolation
AT nagyvivienk novelprotocolforoptimalutilizationofhpsdapproachforpulmonaryveinisolation
AT roithingerfranzxaver novelprotocolforoptimalutilizationofhpsdapproachforpulmonaryveinisolation
AT sallozoltan novelprotocolforoptimalutilizationofhpsdapproachforpulmonaryveinisolation
AT steinwenderclemens novelprotocolforoptimalutilizationofhpsdapproachforpulmonaryveinisolation
AT gellerlaszlo novelprotocolforoptimalutilizationofhpsdapproachforpulmonaryveinisolation
AT matschuckguidoa novelprotocolforoptimalutilizationofhpsdapproachforpulmonaryveinisolation
AT kosiukjedrzej novelprotocolforoptimalutilizationofhpsdapproachforpulmonaryveinisolation